BASF increases cash offer for Pronova BioPharma to NOK 13.50 per share
BASF has increased its cash offer for Pronova BioPharma to NOK 13.50 per share.

Acceptance of more than 90 percent required

Offer period ends on January 18, 2013, 16:30 CET

Ludwigshafen, Germany – January 15, 2013 – BASF [Frankfurt: BAS, LSE: BFA, SWX: AN] confirms its offer to acquire all of the issued and outstanding shares of Pronova BioPharma ASA, Lysaker, Norway, [OBX: PRON], and is increasing its cash offer price to NOK 13.50 per share (previously NOK 12.50). The offer period expires at 16:30 CET on January 18, 2013 and will not be extended.

You will find the long version of the press release in the internet under the following link shown below.
For further information please contact:  Thomas Nonnast
Tel:  +49 30 206 2950-34
Fax:  +49 30 206-2950-20
Click here to Visit Website:
DISCLAIMER: News items are included on the website in good faith. The accuracy of claims or statements made in this news item have not been independently verified by and no responsibility is accepted by for the accuracy of the contents of this news item. Readers are advised that they should carry out additional checks on the accuracy of this news item, and they should also check that any products offered for sale are of a suitable quality and that their use satisfies all legal requirements.